» Articles » PMID: 26793049

Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's Disease

Overview
Journal Front Neurosci
Date 2016 Jan 22
PMID 26793049
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's and Parkinson's disease are the two most common neurodegenerative disorders. They develop after a progressive death of many neurons in the brain. Although therapies are available to treat the signs and symptoms of both diseases, the progression of neuronal death remains relentless, and it has proved difficult to slow or stop. Hence, there is a need to develop neuroprotective or disease-modifying treatments that stabilize this degeneration. Red to infrared light therapy (λ = 600-1070 nm), and in particular light in the near infrared (NIr) range, is emerging as a safe and effective therapy that is capable of arresting neuronal death. Previous studies have used NIr to treat tissue stressed by hypoxia, toxic insult, genetic mutation and mitochondrial dysfunction with much success. Here we propose NIr therapy as a neuroprotective or disease-modifying treatment for Alzheimer's and Parkinson's patients.

Citing Articles

A nanoparticle-based wireless deep brain stimulation system that reverses Parkinson's disease.

Wu J, Cui X, Bao L, Liu G, Wang X, Chen C Sci Adv. 2025; 11(3):eado4927.

PMID: 39813330 PMC: 11734722. DOI: 10.1126/sciadv.ado4927.


Mystery of gamma wave stimulation in brain disorders.

Deng Q, Wu C, Parker E, Zhu J, Liu T, Duan R Mol Neurodegener. 2024; 19(1):96.

PMID: 39695746 PMC: 11657232. DOI: 10.1186/s13024-024-00785-x.


40 Hz light preserves synaptic plasticity and mitochondrial function in Alzheimer's disease model.

Behrooz A, Aghanoori M, Nazari M, Latifi-Navid H, Vosoughian F, Anjomani M Sci Rep. 2024; 14(1):26949.

PMID: 39506052 PMC: 11541745. DOI: 10.1038/s41598-024-78528-7.


Efficacy of Photobiomodulation Therapy in Older Adults: A Systematic Review.

Godaert L, Drame M Biomedicines. 2024; 12(7).

PMID: 39061982 PMC: 11274037. DOI: 10.3390/biomedicines12071409.


A brief literature review of low-level laser therapy for treating amyotrophic lateral sclerosis and confirmation of its effectiveness.

Moskvin S Biomedicine (Taipei). 2024; 14(1):1-9.

PMID: 38533300 PMC: 10962560. DOI: 10.37796/2211-8039.1430.


References
1.
Sabatini U, Boulanouar K, Fabre N, Martin F, Carel C, Colonnese C . Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. Brain. 2000; 123 ( Pt 2):394-403. DOI: 10.1093/brain/123.2.394. View

2.
Blandini F, Nappi G, Tassorelli C, Martignoni E . Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog Neurobiol. 2000; 62(1):63-88. DOI: 10.1016/s0301-0082(99)00067-2. View

3.
Farkas E, De Jong G, de Vos R, Jansen Steur E, Luiten P . Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease. Acta Neuropathol. 2000; 100(4):395-402. DOI: 10.1007/s004010000195. View

4.
Haslinger B, Erhard P, Kampfe N, Boecker H, Rummeny E, Schwaiger M . Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain. 2001; 124(Pt 3):558-70. DOI: 10.1093/brain/124.3.558. View

5.
Bergman H, Deuschl G . Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back. Mov Disord. 2002; 17 Suppl 3:S28-40. DOI: 10.1002/mds.10140. View